Avita Medical, Inc. Common Stock RCEL

$7.85 -2.00% at last close

Analyst Consensus

Consensus Rating
Buy (4 Buy · 0 Hold · 0 Sell)
Average Price Target
$8.25
Implied Upside
+5.1%
Price Target Range
$6.00 – $10.00
Analysts (12 mo)
4

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-08-07
BTIGRyan Zimmerman
Upgrades Neutral → Buy $7
2026-05-15
Lake StreetFrank Takkinen
Upgrades Hold → Buy $4 → $6
2026-04-09
D. Boral CapitalJason Kolbert
Maintains Buy $10
2026-04-08
D. Boral CapitalJason Kolbert
Maintains Buy $10
2026-03-05
Northland Capital MarketsCarl Byrnes
Initiates coverage on Outperform $10
2026-02-17
D. Boral CapitalJason Kolbert
Maintains Buy $10
2026-01-26
D. Boral CapitalJason Kolbert
Maintains Buy $10
2026-01-16
Lake StreetFrank Takkinen
Maintains Hold $3 → $4
2026-01-15
D. Boral CapitalJason Kolbert
Maintains Buy $14 → $10
2025-11-20
BTIGRyan Zimmerman
Upgrades Sell → Neutral
2025-11-07
D. Boral CapitalJason Kolbert
Maintains Buy $14
2025-10-17
Lake StreetFrank Takkinen
Downgrades Buy → Hold $8 → $4
2025-10-17
D. Boral CapitalJason Kolbert
Maintains Buy $14
2025-09-15
D. Boral CapitalJason Kolbert
Maintains Buy $14
2025-09-05
D. Boral CapitalJason Kolbert
Maintains Buy $18 → $14
2025-08-11
Lake StreetBrooks O'Neil
Maintains Buy $14 → $8
2025-08-08
D. Boral CapitalJason Kolbert
Maintains Buy $19 → $18
2025-06-10
D. Boral CapitalJason Kolbert
Maintains Buy $19
2025-06-06
D. Boral CapitalJason Kolbert
Maintains Buy $19
2025-04-10
D. Boral CapitalJason Kolbert
Maintains Buy $22
2025-04-04
D. Boral CapitalJason Kolbert
Maintains Buy $22
2025-03-18
D. Boral CapitalJason Kolbert
Maintains Buy $22
2025-02-20
D. Boral CapitalJason Kolbert
Maintains Buy $25 → $22
2025-02-14
D. Boral CapitalJason Kolbert
Maintains Buy $25
2025-01-08
Lake StreetBrooks O'Neil
Maintains Buy $20 → $14
2025-01-08
D. Boral CapitalJason Kolbert
Maintains Buy $25
2024-12-24
Cantor FitzgeraldRoss Osborn
Reiterates Overweight $21
2024-12-24
D. Boral CapitalJason Kolbert
Initiates coverage on Buy $25
2024-11-08
Piper SandlerMatt O'Brien
Reiterates Neutral $9 → $12
2024-08-09
Cantor FitzgeraldRoss Osborn
Reiterates Overweight $21

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$7.85
Market Cap
$251.13 million
52-Week Range
$3.22 $8.55
Average Volume
538K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.